Sanctuary Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.69M Buy
26,825
+1,325
+5% +$260K 0.03% 567
2026
Q1
$5M Buy
25,500
+824
+3% +$160K 0.03% 563
2025
Q4
$4.28M Buy
24,676
+331
+1% +$60.3K 0.02% 599
2025
Q3
$4.64M Buy
24,345
+254
+1% +$45.1K 0.03% 560
2025
Q2
$4.33M Buy
24,091
+719
+3% +$125K 0.03% 555
2025
Q1
$3.95M Buy
23,372
+1,991
+9% +$327K 0.03% 541
2024
Q4
$3.51M Buy
21,381
+3,412
+19% +$531K 0.02% 638
2024
Q3
$2.94M Buy
17,969
+8,282
+85% +$1.24M 0.02% 703
2024
Q2
$1.3M Buy
+9,687
New +$1.33M 0.01% 1049

Other funds holding DGX

Sanctuary Advisors's DGX Position: Q2 2026 in Review

Sanctuary Advisors increased its Quest Diagnostics (DGX) stake by 5.2% in Q2 2026, buying an estimated $260K and bringing the position to 26,825 shares worth $5.69M. The position accounts for 0.03% of the portfolio, ranked #567.

Sanctuary Advisors first reported a position in DGX in Q2 2024 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Sanctuary Advisors held 26,825 shares of Quest Diagnostics worth $5.69M as of Q2 2026.
  • Sanctuary Advisors bought 1,325 Quest Diagnostics shares in Q2 2026, an estimated $260K.
  • Quest Diagnostics made up 0.03% of Sanctuary Advisors's portfolio in Q2 2026, its #567 holding.
  • Sanctuary Advisors first reported a position in Quest Diagnostics in Q2 2024 and has held it in 9 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.